DUX4-induced dsRNA and MYC mRNA stabilization activate apoptotic pathways in human cell models of facioscapulohumeral dystrophy.
Sean C ShadleJun Wen ZhongAmy E CampbellMelissa L ConerlySujatha JagannathanChao-Jen WongTimothy D MorelloSilvère M van der MaarelStephen J TapscottPublished in: PLoS genetics (2017)
Facioscapulohumeral dystrophy (FSHD) is caused by the mis-expression of DUX4 in skeletal muscle cells. DUX4 is a transcription factor that activates genes normally associated with stem cell biology and its mis-expression in FSHD cells results in apoptosis. To identify genes and pathways necessary for DUX4-mediated apoptosis, we performed an siRNA screen in an RD rhabdomyosarcoma cell line with an inducible DUX4 transgene. Our screen identified components of the MYC-mediated apoptotic pathway and the double-stranded RNA (dsRNA) innate immune response pathway as mediators of DUX4-induced apoptosis. Further investigation revealed that DUX4 expression led to increased MYC mRNA, accumulation of nuclear dsRNA foci, and activation of the dsRNA response pathway in both RD cells and human myoblasts. Nuclear dsRNA foci were associated with aggregation of the exon junction complex component EIF4A3. The elevation of MYC mRNA, dsRNA accumulation, and EIF4A3 nuclear aggregates in FSHD muscle cells suggest that these processes might contribute to FSHD pathophysiology.
Keyphrases
- induced apoptosis
- endoplasmic reticulum stress
- cell cycle arrest
- transcription factor
- oxidative stress
- immune response
- cell death
- signaling pathway
- skeletal muscle
- binding protein
- poor prognosis
- stem cells
- early onset
- pi k akt
- type diabetes
- single cell
- toll like receptor
- adipose tissue
- dna methylation
- cell proliferation
- dendritic cells
- drug delivery
- diabetic rats
- hyaluronic acid
- cancer therapy